It has the potential to have both effects depending on how much your body produces
After blocking, membranes were incubated with primary antibodies against SREBP-1c (1:1500), PPAR (1:2000), FAS (1:1200), SCD1 (1:1500), AMPK (1:1000), NF-B (1:1000), and GAPDH (1:5000), followed by HRP-conjugated secondary antibodies
Its half-life and the reason for discontinuation are factors that determine how to stop taking Ozempic
Human trials need to define the product, route, dose, comparator, outcomes, adverse-event collection, and follow-up before those claims can be tested reliably
Another study found that patients with type 2 diabetes and kidney disease who were prescribed GLP-1s had a 39% higher risk of requiring kidney replacement therapy (dialysis or transplant), compared to patients taking SGLT2 inhibitors